Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Nanomedicine. 2014 Sep 3;11(2):447–456. doi: 10.1016/j.nano.2014.08.005

Figure 3.

Figure 3

Survival curve for groups of 9 BALB/c mice challenged IN with 3 × LD50 B. mallei ATCC 23344, five weeks post-first IN immunisation with 3 × 50 μL doses of LPS or AuNP-TetHc-LPS (A). Colony counts of B. mallei in spleens three weeks post challenge. Each point is the mean of values from five mice. Error bars represent the standard error of the mean; asterisks indicate significant differences (p < 0.05) (B).